In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

AZ CEO Pascal Soriot scored about 13.86 million pounds sterling ($18.76 million) in total pay for 2021, AstraZeneca said in its annual report published (PDF) this month.

AstraZeneca’sAZN-0.29 % decrease; red down pointing triangle longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...